Device Trial Radar · NCT03628378
Orthosensor vs Conventional Total Knee Arthroplasty
Last checked: Nov 19, 2026Latest source record: Sep 24, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
130
Actual
Start
Dec 20, 2017
Primary completion
Jun 22, 2022
Study completion Jun 22, 2022
Sponsor
- Lead sponsor
- Columbia UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 14, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (participant)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
In a randomized-controlled fashion, this investigation will evaluate the use of the Verasense technology to achieve optimal TKA balance. Patients will be randomized to either: 1) undergo manual soft tissue balancing or 2) soft tissue balancing with the Verasense. The primary outcomes of interest will include patient-reported outcomes as well knee range of motion at 3 months, 6 months, 1 year, and 2 years. Secondary outcomes of interest will include pain level as assessed by the visual analogue scale (VAS) in the acute post-operative and follow up periods, ambulation distance during inpatient physical therapy postoperatively, surgical time, tourniquet time, amount of opioid consumption, length of hospital stay, incidence of arthrofibrosis and subsequent manipulation under anesthesia. The investigators hypothesize that the use of the Verasense technology will lead to improved soft tissue balancing in TKA and ultimately result in favorable patient-reported outcomes and postoperative knee range of motion.
Conditions
- Osteoarthritis, Knee
Interventions
VerasenseDevice
Ligamentous balancing device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Average Score on the 12-Item Short Form Survey (SF-12) - Physical ComponentTime frame: 3 months, 1 year, 2 years
- Average Score on the 12-Item Short Form Survey (SF-12) - Mental ComponentTime frame: 3 months, 1 year, 2 years
- Average Score on the WOMAC Functional (F) Limitation SubscaleTime frame: 3 months, 1 year, 2 years
4 more outcomes with a free account
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
NewYork-Presbyterian Lawrence Hospital
Bronxville, New York
Columbia University Irving Medical Center
New York, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.